Portal de Periódicos da CAPES

A Less Common Cause of Acute Hepatitis in Kidney Transplant Recipients: A Case Series

2022; Elsevier BV; Volume: 54; Issue: 5 Linguagem: Inglês

10.1016/j.transproceed.2022.03.037

1873-2623

Ana Luísa Correia, Ana Carolina Pimenta, Eduarda Carias, Maria Guedes Marques, Rita Leal, Luís Rodrigues, Lídia Santos, Catarina Romãozinho, Jorge Leitão, Rui Alves, Arnaldo Figueiredo,

Liver Diseases and Immunity

Hepatitis E virus (HEV) is a cause of significant morbidity and mortality, representing an important global public health problem. Immunocompetent patients with acute hepatitis E can clear the infection spontaneously; however, in approximately two thirds of cases, immunosuppressed patients, such as kidney transplant (KT) recipients, fail to clear the HEV infection and develop chronic hepatitis.We report 3 cases of HEV infection in KT patients. Two presented only with laboratory abnormalities and elevated liver enzymes, and 1 presented with symptomatic disease motivating hospital admission. None was able to clear the infection spontaneously, and they were all treated with ribavirin, accompanied with reduction of immunosuppressive drugs. Adverse effects of the treatment were reported in 2 patients, and in 1 case, a dose reduction was necessary. All patients responded to the treatment and have no current evidence of active disease. No alterations of basal kidney function during or related to the treatment were registered.HEV screening in KT patients presenting with abnormal liver function of undetermined cause is fundamental, as it might have poorer outcomes in this specific population. The treatment with ribavirin seems to be safe and effective, although we must always be alert to potential side effects, maintaining a close follow-up of these patients.